Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001842952-24-000079
Filing Date
2024-09-05
Accepted
2024-09-05 08:15:04
Documents
1
Period of Report
2024-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1725538497.html 4  
1 FORM 4 wk-form4_1725538497.xml 4 3864
  Complete submission text file 0001842952-24-000079.txt   5485
Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Smith Karen L. (Reporting) CIK: 0001639637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 241280001

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)